Clinical Trial Update: Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating hydration strategies and L-carnitine to prevent contrast-induced nephropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Renal Insufficiency

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Acute Kidney Injury, Renal Insufficiency | Phase 3 | Status: TERMINATED